1. Ability of B-Type Natriuretic Peptide Testing to Predict Cardioembolic Stroke in the General Population - Comparisons With C-Reactive Protein and Urinary Albumin.
- Author
-
Nakamura M, Ishibashi Y, Tanaka F, Omama S, Onoda T, Takahashi T, Takahashi S, Tanno K, Ohsawa M, Sakata K, Koshiyama M, Ogasawara K, and Okayama A
- Subjects
- Aged, Albuminuria, Area Under Curve, Biomarkers analysis, Embolism epidemiology, Female, Humans, Incidence, Male, Middle Aged, Myocardial Infarction epidemiology, Predictive Value of Tests, Proportional Hazards Models, ROC Curve, Risk Factors, Stroke, Albumins analysis, C-Reactive Protein analysis, Embolism diagnosis, Myocardial Infarction diagnosis, Natriuretic Peptide, Brain blood
- Abstract
Background: The ability of cardiovascular biomarkers to predict the incidence of stroke subtypes remains ill-defined in the general population., Methods and results: The blood levels of B-type natriuretic peptide (BNP) and high-sensitivity C-reactive protein (hs-CRP) and urinary albumin corrected by urinary creatinine (UACR) were determined in a general population (n=13,575). The ability to predict the incidence of ischemic stroke subtypes (lacunar, atherothrombotic, cardioembolic) for each biomarker was assessed based on the area under the receiver-operating characteristic curve (AUC-ROC) and using Cox proportional hazard modeling. The predictive abilities of UACR and hs-CRP for any subtype of ischemic event were found to be suboptimal. However, the ability of BNP to predict the incidence of cardioembolic stroke was excellent (AUC-ROC=0.81). When BNP was added to established stroke risk factors, the ability to predict cardioembolic stroke in terms of the AUC-ROC significantly improved (4-year follow-up, P=0.018; 8-year follow-up, P=0.009). Furthermore, when BNP was added to the JPHC score, the ability to predict cardioembolic stroke was significantly improved (net reclassification improvement=0.968, P<0.0001: integrated discrimination improvement=0.039, P<0.05)., Conclusions: In the general population, plasma BNP was an excellent biomarker for predicting the incidence of cardioembolic stroke when used alone or in combination with established stroke risk factors.
- Published
- 2018
- Full Text
- View/download PDF